American Association for Cancer Research

Continuing Medical Education (CME)

ACCREDITATION STATEMENT

The American Association for Cancer Research (AACR) is accredited by ACCME to provide continuing medical education activities for physicians.


CREDIT DESIGNATION STATEMENT

AACR designates this educational activity for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES

Improvements in diagnosis, treatment and prevention of cancer are closely linked to the development of state-of-the-art techniques and the future progress of cancer research. The dissemination of information about current and future techniques and cancer treatment from the researchers developing the treatments to the physician who treat the patients is crucial in order to ensure advances in cancer treatment, diagnosis, and prevention.


The AACR and the Roswell Park Cancer Institute have partnered to present this AACR Centennial Symposium on the “The Future of Cancer Research: Science and Patient Impact.” The symposium will bring together investigators from around the world to share their expertise regarding the advances in basic science and clinical translation, as well as cutting edge clinical techniques, with the oncologists, internists, and oncology nurses. The symposium begins with educational sessions that have been designed to establish a baseline level of information on both current clinical techniques, such as the use of molecular markers in the clinic, and cutting edge laboratory technologies, which are being translated to the clinic. The remaining four plenary sessions are designed to describe the latest laboratory breakthroughs in the context of the potential impact on patient care. Topics include advances in both experimental and molecular therapeutics, proteomics and systems biology, cancer genomics, prevention, and molecular epidemiology.

It is the advances on the cutting edge of translational research that bring about improvements in patient care. Dissemination and exchange of ideas about current and future techniques are imperative to expanding the knowledge base of physicians and thereby, creating a higher standard of care for cancer patients.

    After participating in this CME activity, physicians should be able to:
  • Explain how molecular markers and mechanisms are currently being applied to the clinic and patient treatment.
  • Identify targets, focusing on epigenetic contributions in the tumor microenvironment, that can be and are being used to treat cancer.
  • Assess how the emerging fields of proteomics and systems biology can be used to facilitate the development of cancer therapies.
  • Articulate the role of molecular epidemiology in cancer prevention research.

DISCLOSURE STATEMENT

Information presented at AACR-sponsored CME activities will be unbiased and based on scientific evidence. AACR will provide information that Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program and Proceedings of this conference.


CLAIMING CME CREDIT

The deadline for the submission of requests for credit for CME has elapsed. Please contact the AACR Office of CME at cme@aacr.org or (215) 440-9300 with further inquiries.
 

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

Supporters of this activity are listed in the Final Program.